Blog

02 Feb

Publications

Open-label adhesion performance studies of a new lidocaine topical system 1.8% versus lidocaine patches 5% and lidocaine medicated plaster 5% in healthy subjects.

September 2, 2021
Posted by Jitendra

15 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

14 Jan

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

11 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

08 Jan

SEC FIlings

Prospectus

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Notice of Effectiveness

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Registration adding securities to prior Form S-1 registration

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Certification

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Registration of securities

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

Open-label adhesion performance studies of a new lidocaine topical system 1.8% versus lidocaine patches 5% and lidocaine medicated plaster 5% in healthy subjects.

Current report

Statement of acquisition of beneficial ownership by individuals

Current report

Prospectus

Notice of Effectiveness

Registration adding securities to prior Form S-1 registration

Certification

Registration of securities

Initial statement of beneficial ownership of securities

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch